Activation of reactive oxygen species and the renin-angiotensin system in iga nephropathy model mice

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 5-6, 2009, Pages 509-515

  Ohashi, Naro ^a   Katsurada, Akemi ^a   Miyata, Kayoko ^a   Satou, Ryousuke ^a   Saito, Toshie ^a   Urushihara, Maki ^a   Kobori, Hiroyuki ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

IgA nephropathy; Reactive oxygen species; Renin angiotensin system

Indexed keywords

8 ISOPROSTANE; ANGIOTENSIN II; ANGIOTENSINOGEN; IMMUNOGLOBULIN A; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL MOUSE; KIDNEY DISEASE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; ANGIOTENSINS; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS, IGA; MALE; MESANGIAL CELLS; MICE; MICE, INBRED BALB C; REACTIVE OXYGEN SPECIES; RENIN-ANGIOTENSIN SYSTEM;

EID: 65349156816     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.05107.x     Document Type: Article

References (43)

1. Barratt J, Feehally J. IgA nephropathy. J. Am. Soc. Nephrol. 2005 16 : 2088 97. (Pubitemid 41716440)
2. Rivera F, Lopez-Gomez JM, Perez-Garcia R. Frequency of renal pathology in Spain 1994-1999. Nephrol. Dial. Transplant. 2002 17 : 1594 602.
3. Schena FP. Survey of the Italian registry of renal biopsies. Frequency of the renal diseases for 7 consecutive years. The Italian Group of Renal Immunopathology. Nephrol. Dial. Transplant. 1997 12 : 418 26.
4. Simon P, Ramee MP, Boulahrouz R et al. Epidemiologic data of primary glomerular diseases in western France. Kidney Int. 2004 66 : 905 8. (Pubitemid 39120990)
5. Research Group on Progressive Chronic Renal Disease. Nationwide and long-term survey of primary glomerulonephritis in Japan as observed in 1850 biopsied cases. Nephron 1999 82 : 205 13. (Pubitemid 29308679)
6. Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China. Analysis based on 13 519 renal biopsies. Kidney Int. 2004 66 : 920 3. (Pubitemid 39120993)
7. Briganti EM, Dowling J, Finlay M et al. The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol. Dial. Transplant. 2001 16 : 1364 7. (Pubitemid 32640589)
8. Nair R, Walker PD. Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney Int. 2006 69 : 1455 8.
9. Dillon JJ. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy. Semin. Nephrol. 2004 24 : 218 24. (Pubitemid 38685991)
10. Kobori H, Ozawa Y, Suzaki Y et al. Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases. Am. J. Hypertens. 2006 19 : 541 50.
11. Kobori H, Katsurada A, Ozawa Y et al. Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients. Biochem. Biophys. Res. Commun. 2007 358 : 156 63. (Pubitemid 46719097)
12. Kobori H, Nishiyama A, Abe Y, Navar LG. Enhancement of intrarenal angiotensinogen in Dahl-salt-sensitive rats on high salt diet. Hypertension 2003 41 : 592 7. (Pubitemid 36314637)
13. Kobori H, Nishiyama A. Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats. Biochem. Biophys. Res. Commun. 2004 315 : 746 50. (Pubitemid 38229405)
14. Suzaki Y, Ozawa Y, Kobori H. Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats. Int. J. Biol. Sci. 2007 3 : 40 6. (Pubitemid 46155759)
15. Miyata K, Ohashi N, Suzaki Y, Katsurada A, Kobori H. Sequential activation of the reactive oxygen species/angiotensinogen/renin angiotensin system axis in renal injury of type 2 diabetic rats. Clin. Exp. Pharmacol. Physiol. 2008 35 : 922 7.
16. Walker LA, Gellai M, Valtin H. Renal response to pentobarbital anesthesia in rats: Effect of interrupting the renin-angiotensin system. J. Pharmacol. Exp. Ther. 1986 236 : 721 8. (Pubitemid 16080071)
17. Kobori H, Katsurada A, Miyata K et al. Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA. Am. J. Physiol. Renal Physiol. 2008 294 : F1257 63.
18. Kobori H, Ozawa Y, Satou R et al. Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. Am. J. Physiol. Renal Physiol. 2007 293 : F938 45. (Pubitemid 47403366)
19. Katsurada A, Hagiwara Y, Miyashita K et al. Novel sandwich ELISA for human angiotensinogen. Am. J. Physiol. Renal Physiol. 2007 293 : F956 60. (Pubitemid 47403368)
20. Ozawa Y, Kobori H. Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury. Am. J. Physiol. Renal Physiol. 2007 293 : F100 9. (Pubitemid 47345008)
21. Kobori H, Ozawa Y, Suzaki Y, Nishiyama A. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J. Am. Soc. Nephrol. 2005 16 : 2073 80. (Pubitemid 41716438)
22. Ozawa Y, Kobori H, Suzaki Y, Navar LG. Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am. J. Physiol. Renal Physiol. 2007 292 : F330 9. (Pubitemid 46105273)
23. Patrono C, FitzGerald GA. Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease. Arterioscler. Thromb. Vasc. Biol. 1997 17 : 2309 15. (Pubitemid 28015962)
24. Ji C, Kozak KR, Marnett LJ. IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. J. Biol. Chem. 2001 276 : 18 223 8. (Pubitemid 37411392)
25. Barisoni L, Madaio MP, Eraso M, Gasser DL, Nelson PJ. The kd/kd mouse is a model of collapsing glomerulopathy. J. Am. Soc. Nephrol. 2005 16 : 2847 51.
26. Miyawaki S, Muso E, Takeuchi E et al. Selective breeding for high serum IgA levels from noninbred ddY mice: Isolation of a strain with an early onset of glomerular IgA deposition. Nephron 1997 76 : 201 7. (Pubitemid 27254648)
27. Muso E, Yoshida H, Takeuchi E et al. Enhanced production of glomerular extracellular matrix in a new mouse strain of high serum IgA ddY mice. Kidney Int. 1996 50 : 1946 57. (Pubitemid 26417538)
28. Montero A, Munger KA, Khan RZ et al. F2-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes. Kidney Int. 2000 58 : 1963 72.
29. Kobori H, Harrison-Bernard LM, Navar LG. Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int. 2002 61 : 579 85. (Pubitemid 34102599)
30. Chan LY, Leung JC, Tang SC, Choy CB, Lai KN. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. J. Am. Soc. Nephrol. 2005 16 : 2306 17. (Pubitemid 41725048)
31. Kobori H, Harrison-Bernard LM, Navar LG. Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension 2001 37 : 1329 35. (Pubitemid 34163590)
32. Ingelfinger JR, Jung F, Diamant D et al. Rat proximal tubule cell line transformed with origin-defective SV40 DNA: Autocrine ANG II feedback. Am. J. Physiol. 1999 276 : F218 27. (Pubitemid 29102286)
33. Prieto-Carrasquero MC, Harrison-Bernard LM, Kobori H et al. Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension 2004 44 : 223 9. (Pubitemid 39014242)
34. Del Prete D, Gambaro G, Lupo A et al. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int. 2003 64 : 149 59. (Pubitemid 36714167)
35. Sato M, Hotta O, Taguma Y. Glomerulo-tubular junction stenosis as a factor contributing to glomerular obsolescence in IgA nephropathy. J. Pathol. 2002 197 : 14 19. (Pubitemid 34450159)
36. Lai KN, Leung JC, Lai KB, To WY, Yeung VT, Lai FM. Gene expression of the renin-angiotensin system in human kidney. J. Hypertens. 1998 16 : 91 102. (Pubitemid 28069825)
37. Kashem A, Endoh M, Yamauchi F et al. Superoxide dismutase activity in human glomerulonephritis. Am. J. Kidney Dis. 1996 28 : 14 22. (Pubitemid 26231461)
38. Lemley KV, Lafayette RA, Safai M et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int. 2002 61 : 1475 85. (Pubitemid 34304509)
39. Hishiki T, Shirato I, Takahashi Y, Funabiki K, Horikoshi S, Tomino Y. Podocyte injury predicts prognosis in patients with IgA nephropathy using a small amount of renal biopsy tissue. Kidney Blood Press. Res. 2001 24 : 99 104. (Pubitemid 32642062)
40. Maschio G, Cagnoli L, Claroni F et al. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: A multicentre, randomized, placebo-controlled study. Nephrol. Dial. Transplant. 1994 9 : 265 9. (Pubitemid 24111575)
41. Russo D, Pisani A, Balletta MM et al. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am. J. Kidney Dis. 1999 33 : 851 6. (Pubitemid 29214680)
42. Sachetelli S, Liu Q, Zhang SL et al. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int. 2006 69 : 1016 23. (Pubitemid 43372176)
43. Hsieh TJ, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Chan JS. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 2002 143 : 2975 85.